About Echelon Biosciences
Echelon Biosciences is a company based in Salt Lake City (United States) founded in 1997 was acquired by VION Biosciences in August 2024.. Echelon Biosciences offers products and services including Lipids, Bioassays & Kits, Antibodies & Proteins, Peptides, and Biochemical Reagents. Echelon Biosciences operates in a competitive market with competitors including GlyTech, Iceni Glycoscience, GlycoSpot, Avanti Polar Lipids and TFChem, among others.
- Headquarter Salt Lake City, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$399.29 K (USD), Grant
Sep 20, 2024
-
Investors
NIH
& 4 more
-
Employee Count
Employee Count
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Echelon Biosciences
Echelon Biosciences offers a comprehensive portfolio of products and services, including Lipids, Bioassays & Kits, Antibodies & Proteins, Peptides, and Biochemical Reagents. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Products for lipid research and disease diagnostics
Kits for running samples in assays
Antibodies for protein detection in research
Peptides for scientific synthesis and analysis
Reagents for lipid and cell signaling studies
Unlock access to complete
Funding Insights of Echelon Biosciences
- Total Funding Total Funding
- Total Rounds 22
- Last Round Grant — $399,293
-
First Round
First Round
(05 Nov 2002)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2024 | Amount | Grant - Echelon Biosciences | Valuation |
investors |
|
| Jan, 2019 | Amount | Grant - Echelon Biosciences | Valuation |
investors |
|
| Aug, 2014 | Amount | Grant - Echelon Biosciences | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Echelon Biosciences
Echelon Biosciences has secured backing from 5 investors, including institutional investors. Prominent investors backing the company include NIH, HHS and National Science Foundation. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Drug discovery services are provided to the biopharma sector.
|
Founded Year | Domain | Location | |
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location | |
|
A government-backed foundation providing seed-stage investments to support small businesses.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Echelon Biosciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Echelon Biosciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Echelon Biosciences Comparisons
Competitors of Echelon Biosciences
Echelon Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GlyTech, Iceni Glycoscience, GlycoSpot, Avanti Polar Lipids and TFChem, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Human-type Asp-linked glycans are supplied for research applications.
|
|
| domain | founded_year | HQ Location |
Glycoscience platform is provided for diagnostic and therapeutic applications.
|
|
| domain | founded_year | HQ Location |
High-throughput enzyme screening solutions are developed and provided.
|
|
| domain | founded_year | HQ Location |
Phospholipids and lipids are manufactured for life science applications.
|
|
| domain | founded_year | HQ Location |
Fluoride chemistry is utilized to design glycomimetic drug compounds.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Echelon Biosciences
Frequently Asked Questions about Echelon Biosciences
When was Echelon Biosciences founded?
Echelon Biosciences was founded in 1997 and raised its 1st funding round 5 years after it was founded.
Where is Echelon Biosciences located?
Echelon Biosciences is headquartered in Salt Lake City, United States. It is registered at Salt Lake City, Utah, United States.
What does Echelon Biosciences do?
Echelon Biosciences is a biotech company manufacturing reagents and assays with a strong focus on research on lipid biology. The company was formed in 1997 as a spin-off from the Center for Cell Signaling at the University of Utah and changed hands once in 2005 (Aeterna Zentaris) before being acquired by Frontier Scientific Inc. in 2007. The companys focus is on the development of novel assays and reagents for lipid research and drug discovery (with a focus on cancer, liver disease, allergies, Type II diabetes, and anti-infectives). The companys products include chemical reagents (such as phosphoinositide derivatives, inositol phosphates, lipids, isoprenoids, Heme pathway intermediates, and thiol-reactive probes), biological reagents (such as lipid modifying enzymes, kinases and phosphatases, histone modifying enzymes, enzyme inhibitors and substrates, antibodies and antigens, LPA3 selective ligands, lipid coated beads, lipid strips and arrays, lipid coated plates and microarrays, reagents for lipid delivery, cell viability studies, DNARNA purification) and assays (such as kinase assays, phosphatase assays, hydrolase assays, lipid detection assays, biomarker assays, etc). The company also provides protein detection and assay development services to clients.
Who are the top competitors of Echelon Biosciences?
Echelon Biosciences's top competitors include GlyTech, Iceni Glycoscience and GlycoSpot.
What products or services does Echelon Biosciences offer?
Echelon Biosciences offers Lipids, Bioassays & Kits, Antibodies & Proteins, Peptides, and Biochemical Reagents.
Who are Echelon Biosciences's investors?
Echelon Biosciences has 5 investors. Key investors include NIH, HHS, National Science Foundation, VION Biosciences, and Frontier Chemical.